You are here: Industry Insights > facility

News List

Vetter's Skokie Site Nears Completion contractpharma
April 17, 2019
When completed, the facility will have more than double the overall storage space.
Almac Expands Global Analytical Services Capability contractpharma
April 16, 2019
To bolster operations at its Athlone facility.
FDA identifies hundreds of devices affected by sterilisation facility closures europeanpharmaceuticalreview
April 15, 2019
FDA has launched a notification system where device manufacturers and users may notify the agency of any shortages or related supply issues stemming from sterilisation facility shutdowns…
Catalent opens second clinical supply facility in Shanghai fiercepharma
April 14, 2019
With drug development among both Chinese and Western biotechs and drugmakers escalating rapidly, Catalent has doubled down on its clinical supply capabilities in Shanghai.
Continuous wet granulation manufacturing collaboration europeanpharmaceuticalreview
April 10, 2019
The new facility, built as part of a project called PROSPECT CP, will include blending and feeding of raw materials, twin screw wet granulation, drying and ultimately tabletting…
LA BioMed Opens Medical Research Building contractpharma
April 03, 2019
$63-million, four-story, 78,000 square-foot facility is one of the most advanced in the country
As Merck Research Laboratories moves into new facility, 20 staffers get the ax fiercepharma
April 03, 2019
Merck is set to cut 20 staffers from its Research Laboratories unit as it prepares to enter its new digs in South San Francisco.
Asymchem Completes HPAPI Facility Inspection contractpharma
March 28, 2019
Asymchem has announced that its Tianjin1 site, a dedicated High Potency Active Pharmaceutical Ingredients (HPAPI) development and manufacturing facility, successfully completed a U.S. Food and Drug Administration general GMP reinspection conducted between
MaSTherCell Announces New Cell & Gene Therapy Mfg. Site contractpharma
March 28, 2019
Facility will become a state-of-the-art manufacturing and production site designed for late-stage and commercially-approved cell & gene therapy products by 2021.
MilliporeSigma, GenScript to Accelerate Cell and Gene Therapy Industrialization in China contractpharma
March 20, 2019
MilliporeSigma has signed a collaboration agreement with China-based GenScript focusing on plasmid and viral vector manufacturing.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page